Allegheny Health Network Among 15 Centers Nationwide

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Allegheny Health Network Among 15 Centers Nationwide Launching Clinical Trial of Non-Surgical Weight Loss Balloon

PITTSBURGH, Pa., April 24, 2015 (GLOBE NEWSWIRE) -- via PRWEB - Allegheny Health Network today announced its participation in the first U.S. clinical trial evaluating the effectiveness of a non-surgical alternative, the Obalon Balloon, in helping people lose weight.

A team led by George M. Eid, MD , FACS, FASMBS, System Division Chief, Minimally Invasive Surgery, and System Director, Bariatric and Metabolic Institute , will examine whether the Obalon Balloon, which is placed when the patient swallows an inflatable capsule, can help people who have struggled to lose weight with diet and exercise.

"Many patients need help losing weight but are not interested in, or don't qualify for, bariatric surgery," Dr. Eid said. "The Obalon Balloon could offer an alternative that is discreet, non-surgical and reversible, leading to progressive weight loss over a six-month period."

With the progressive Obalon approach, a total of three balloons are placed over several weeks. The patient swallows the capsule containing the balloon, then it is inflated with gas. The balloon is designed to occupy space in the stomach so that the patient feels fuller and eats less. After six months, the balloons are removed in an outpatient procedure, using a flexible tube/camera that is inserted into the mouth.

Participants in the study will be randomized into two groups; one will receive the Obalon Balloon, the other, a sham device. All patients will receive diet and exercise counseling. After six months, the balloons will be removed and patients will be told if they received the balloon or a sham.

Patients who received the balloon will then begin a second six-month weight loss session without the balloons, continuing to visit their doctor's office for diet and exercise counseling. Those who did not receive the balloon but still qualify for the study, will have the option to receive the Obalon Balloon at no cost.

The Obalon Balloon is not currently commercially available in the U.S., but is approved in some European countries.

To qualify, patients must be 22 to 64 years old, have a Body Mass Index between 30 and 40, not have had or be considering bariatric surgery, and able to attend regular appointments over a one-year period.

For more information, call 1-855-878-8390 or visit http://www.BalloonTrial.com

About the Allegheny Health Network:

Allegheny Health Network, part of Highmark Health, is an integrated healthcare delivery system serving the Western Pennsylvania region. The Network is comprised of eight hospitals, including its flagship academic medical center Allegheny General Hospital, Allegheny Valley Hospital, Canonsburg Hospital, Forbes Hospital, Jefferson Hospital, Saint Vincent Hospital, Westfield Memorial Hospital and West Penn Hospital; a research institute; Health + Wellness Pavilions; an employed physician organization, home and community based health services and a group purchasing organization. The Network employs approximately 17,500 people and has more than 2,100 physicians on its medical staff. The Network also serves as a clinical campus for Temple University School of Medicine, Drexel University College of Medicine and the Lake Erie College of Osteopathic Medicine.

This article was originally distributed on PRWeb. For the original version including any supplementary images or video, visit http://www.prweb.com/releases/2015/04/prweb12678970.htm

Allegheny General Hospital Stephanie Waite +1 412-330-4434

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 269

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
China's 15th Plan: Key Moves in the Capital Markets

Updated Category News Views 127

Riding the Waves of Reform in China The winds of change are blowing through China's capital markets, and Guosen Securities is putting a stake in the ground with bold priorities for the 15th Five-Year Plan. As far as I'm concerned, the headlines here are thick with implications for anyone eyeing a piece of China's economic pie from 2026–2030. The Pillars of Stability and...

Continue Reading
CStone's CS2009: A Leap in Cancer Treatment Validated

Updated Category News Views 59

CStone's Game-Changer: CS2009 in the Spotlight CStone Pharmaceuticals just pulled a rabbit out of a hat at the ESMO 2026 Congress, showcasing the clinical might of their CS2009. This ain't just another hype train, folks. We're talking about a trispecific antibody targeting PD-1, VEGF, and CTLA-4. With data rolled out from over 300 patients, this compound promises a...

Continue Reading
NOTHING NINE's Global Ambitions: Paris Show's Impact

Updated Category News Views 83

Paris: Stage or Launchpad? You’d think walking that catwalk in Paris is the holy grail—fashion's own illustrious red carpet. But when you're Chloe, founder of NOTHING NINE, the real hustle kicks off once the lights dim. On 29th September 2026, this designer brand strutted its stuff at one of the grandest venues, Les Invalides, part of the prestigious Paris Fashion...

Continue Reading
Ambient AI Shows Promise for Boosting Cancer Care Efficiency

Updated Category News Views 13

Study Points to Ambient AI's Promise in Oncology Some days, the world of cancer care is a real beast to tackle. But today, we've got a glimpse into how technology, and specifically ambient AI, might just help slay some of the burdens that these healthcare warriors face daily. The Florida Cancer Specialists & Research Institute (FCS) joined hands to dive into how this tech...

Continue Reading
Superteam Wheels Rides Into Spain with RACEIT Deal

Updated Category News Views 63

Rolling Out the Red Carpet for Spanish Cyclists Think of it as the pedal-powered bridge from wherever Superteam Wheels calls home to the sunny streets of Spain. If you're in the cycling game, this new partnership between Superteam Wheels and COMERTECH RACEIT, S.L., better known as RACEIT, is drawing a line in the sand—or perhaps on the asphalt—across Europe. Starting...

Continue Reading
Zinzino Eyes European Market With New Botanical Line

Updated Category News Views 98

Zinzino's Strategic Play in Europe's Wellness Market There's a new player on the European wellness block, and it's Zinzino's latest concoction of fermented botanical supplements. This isn't just your run-of-the-mill vitamin shop stock; we're talking about a lineup crafted for distinct parts of the day, reflecting an evolving consumer trend. People are looking for tailored...

Continue Reading
HCLTech Partners with Rapidus on Semiconductor Future

Updated Category News Views 81

Making Sense of the HCLTech and Rapidus Collaboration When you're talking about the world of semiconductors, no two words get tossed around more than innovation and speed. Now, with the recent partnership between HCLTech and Rapidus, those words are bound to echo from India to Japan and beyond. We have HCLTech, a stalwart of global technology, teaming up with Rapidus, a...

Continue Reading
ASICS and University of Michigan Launch Innovation Lab

Updated Category News Views 88

Running Innovation Gets a Boost in Ann Arbor On a crisp fall day up in Ann Arbor, ASICS and the University of Michigan have decided it's high time to shake up the world of running product R&D. These two powerhouses just launched the ASICSx Michigan Sport Innovation Center (AMSI), an academic-industry research lab. It's like they're mixing college smarts with business...

Continue Reading
Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 412

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading

Top 5 Most Recently Viewed Articles

TuHURA Biosciences Advances Phase 3 Trial for Cancer Treatment

Updated Category News Views 229

TuHURA Biosciences Moves Forward with Phase 3 Trial TuHURA Biosciences, Inc. (NASDAQ: HURA) is making substantial strides in the field of cancer immunotherapy. The company is geared up to launch its Phase 3 accelerated approval trial of IFx-2.0, a promising adjunctive therapy in combination with Keytruda (pembrolizumab), targeting advanced and metastatic Merkel cell...

Continue Reading
Fiserv, Inc. Lawsuit: Investors Can Fight Back Against Losses

Updated Category News Views 198

Introduction to the Class Action Lawsuit In recent news, numerous investors in Fiserv, Inc. are being alerted to an important opportunity. A class action lawsuit has been initiated targeting Fiserv, a prominent figure in the financial services tech sector. This situation arises from allegations of significant financial losses endured by shareholders due to the Company's...

Continue Reading
Exploring Humana's Decreased Short Interest and Market Impact

Updated Category News Views 104

Understanding Humana's Short Interest Trends Recently, Humana Inc (NYSE: HUM) has reported a notable decline in its short percent of float, decreasing by 6.3% since the previous report. As of now, the company has approximately 4.30 million shares sold short, which constitutes about 3.57% of the total shares available for trading. Based on the current trading volumes, it...

Continue Reading
Innovative Restaurant Launch Featuring AI Robots Opens Soon

Updated Category News Views 344

AI-Driven Restaurant Opening at Walmart Supercenter In an exciting development for the dining industry, Richtech Robotics Inc. (NASDAQ: RR), a leader in AI-driven service robots, has joined forces with Ghost Kitchens America to unveil their latest One Kitchen restaurant. This location, situated within a Walmart Supercenter, is marking a significant milestone as it becomes...

Continue Reading
Choosing the Perfect MySmile Teeth Whitening Solution for You

Updated Category News Views 82

Your Guide to MySmile Teeth Whitening Products Achieving a whiter, brighter smile is easier than ever with MySmile's effective teeth whitening solutions. MySmile offers a range of products tailored to fit different lifestyles; whether you're interested in an all-in-one kit, convenient whitening strips, or one-step solutions, the right product is just a choice away. Let's...

Continue Reading